Cargando…

Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?

INTRODUCTION: Introduction: Residual depressive symptoms are common after a successful acute treatment of late-life depression (LLD), and their presence predicts increased risk of relapse. While electroconvulsive therapy (ECT) is the most effective treatment for LLD, little is known about which part...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambrichts, S., Vansteelandt, K., Wagenmakers, M., Oudega, M., Obbels, J., Dols, A., Bouckaert, F., Sienaert, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563668/ http://dx.doi.org/10.1192/j.eurpsy.2022.460

Ejemplares similares

The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression
por: Loef, Dore, et al.
Publicado: (2021)

Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome
por: van Zutphen, Elisabeth Maria, et al.
Publicado: (2019)

Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait
por: Sienaert, Pascal, et al.
Publicado: (2020)

A longitudinal study of the association between basal ganglia volumes and psychomotor symptoms in subjects with late life depression undergoing ECT
por: Van Cauwenberge, M. G. A., et al.
Publicado: (2021)

White matter changes following electroconvulsive therapy for depression: a multicenter ComBat harmonization approach
por: Belge, Jean-Baptiste, et al.
Publicado: (2022)

Suicidal ideation and ECT, ECT and suicidal ideation: A register study
por: Sienaert, Pascal, et al.
Publicado: (2022)

White matter changes following electroconvulsive therapy for depression: a mega-analysis
por: Belge, J.-B., et al.
Publicado: (2022)

Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients
por: Loef, Dore, et al.
Publicado: (2023)

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods
por: Henstra, Marieke J., et al.
Publicado: (2022)

Partial remission, residual symptoms, and relapse in depression
por: Paykel, E.S.
Publicado: (2008)

Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapy
por: Opel, Nils, et al.
Publicado: (2021)

Exploring resting state connectivity in patients with psychotic depression
por: Oudega, Mardien L., et al.
Publicado: (2019)

Hippocampal volume change following ECT is mediated by rs699947 in the promotor region of VEGF
por: Van Den Bossche, Maarten J. A., et al.
Publicado: (2019)

The Leuven late life depression (L3D) study: PET-MRI biomarkers of pathological brain ageing in late-life depression: study protocol
por: Emsell, Louise, et al.
Publicado: (2021)

The dynamical signature of anhedonia in major depressive disorder: positive emotion dynamics, reactivity, and recovery
por: Heininga, Vera E., et al.
Publicado: (2019)

Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy: A retrospective cohort study
por: Kurimoto, Naoki, et al.
Publicado: (2021)

Successful electroconvulsive therapy for depression in a man with cerebral amyloid angiopathy
por: Schurgers, Geert, et al.
Publicado: (2021)

The impact of residual symptoms on relapse and quality of life among Thai depressive patients
por: Hiranyatheb, Thanita, et al.
Publicado: (2016)

Hypochondriacal delusion in an elderly woman recovers quickly with electroconvulsive therapy
por: Dols, Annemieke, et al.
Publicado: (2012)

Electroconvulsive Therapy on Severe Obsessive-Compulsive Disorder Comorbid Depressive Symptoms
por: Liu, Xiaohui, et al.
Publicado: (2014)

Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: protocol for a systematic review and network meta-analysis
por: Nikolin, Stevan, et al.
Publicado: (2022)

Depression, memory and electroconvulsive therapy
por: Coetzer, Rudi
Publicado: (2019)

Biophysical mechanisms of electroconvulsive therapy-induced volume expansion in the medial temporal lobe: A longitudinal in vivo human imaging study
por: Takamiya, Akihiro, et al.
Publicado: (2021)

Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression
por: Tominaga, Keiichiro, et al.
Publicado: (2011)

Neuronal network mechanisms associated with depressive symptom improvement following electroconvulsive therapy
por: Takamiya, Akihiro, et al.
Publicado: (2021)

The Global ECT-MRI Research Collaboration (GEMRIC): Establishing a multi-site investigation of the neural mechanisms underlying response to electroconvulsive therapy
por: Oltedal, Leif, et al.
Publicado: (2017)

Late to respond, but early to relapse - An abnormal course of electroconvulsive therapy in treatment-resistant schizophrenia during times of COVID-19
por: Qureshi, Haris, et al.
Publicado: (2022)

Movement, mood and cognition: Preliminary insight into the effects of electroconvulsive therapy in depression through a data-driven resting-state connectivity analysis
por: Belge, J.-B., et al.
Publicado: (2021)

Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
por: Deng, Zhi-De, et al.
Publicado: (2023)

Neuroimaging study of electroconvulsive therapy for depression
por: Chen, Xiaolu, et al.
Publicado: (2023)

Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)
por: Finnegan, Martha, et al.
Publicado: (2016)

Study of effect of nimodipine and acetaminophen on postictal symptoms in depressed patients after electroconvulsive therapy (SYNAPSE)
por: Verdijk, Joey P. A. J., et al.
Publicado: (2022)

PS158. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression
por: Itagake, Kei, et al.
Publicado: (2016)

A retrospective case series of electroconvulsive therapy in the management of depression and suicidal symptoms in adolescents
por: Chen, Xiaolu, et al.
Publicado: (2022)

Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research Collaboration
por: Takamiya, Akihiro, et al.
Publicado: (2021)

Inter and intra-hemispheric structural imaging markers predict depression relapse after electroconvulsive therapy: a multisite study
por: Wade, Benjamin S. C., et al.
Publicado: (2017)

Effectiveness of Electroconvulsive Therapy for Preventing Relapse and Recurrence of Depression in Adults With Major Depressive Disorder: An Updated Meta-Analysis of Randomized Clinical Trials
por: Dar, Hassaan, et al.
Publicado: (2023)

Web-Based Intervention in Mindfulness Meditation for Reducing Residual Depressive Symptoms and Relapse Prophylaxis: A Qualitative Study
por: Boggs, Jennifer M, et al.
Publicado: (2014)

PBMC telomerase activity in depression and the response to electroconvulsive therapy
por: Ryan, Karen M., et al.
Publicado: (2021)

Fronto-medial electrode placement for electroconvulsive treatment of depression
por: Steele, J. Douglas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6kh1nqike5ivpr5kj25goh90s